StockData
QTEXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

QTREX Quantum Ltd.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 26, 2026
$1.40−0.10 (-6.67%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

Earnings

Quarterly results announced on Form 8-K, Item 2.02

QuarterReportedTimeRevenueEPS (GAAP)EPS (adjusted)
Q2 FY2025
Ended Jun 30, 2025
Oct 1, 2025Before market open–––
Q4 FY2024
Ended Dec 31, 2024
Mar 11, 2025Before market open–––
Q4 FY2023
Ended Dec 31, 2023
Mar 25, 2024Before market open–––
Q2 FY2023
Ended Jun 30, 2023
Aug 10, 2023Before market open–––
Q4 FY2022
Ended Dec 31, 2022
Apr 4, 2023During market hours–––
Q2 FY2022
Ended Jun 30, 2022
Aug 11, 2022During market hours–––
Q4 FY2021
Ended Dec 31, 2021
Mar 31, 2022After market close–––

Company guidance

Outlook given with results on Oct 1, 2025, compared with the previous outlook

MeasurePeriodGuidancevs. prior
annual revenue run rate2026$70.00MNew

Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.

Press releases

Announcements QTREX Quantum filed with the SEC